checkAd
    Startseite > Aktien > Eagle Pharmaceuticals > Nachrichten
    Eagle Pharmaceuticals Aktie
    4,3100
     
    USD
    -5,27 %
    -0,2400 USD
    Letzter Kurs 21:04:24 Nasdaq
    4,2900
     
    USD
    400 STK
    Geldkurs 21:07:36
    4,3300
     
    USD
    600 STK
    Briefkurs 21:07:36
    ISIN: US2697961082 · WKN: A1XEDS · SYM: EGRX · USA

    Neueste Nachrichten

    Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida
    15.04.24 · globenewswire · Eagle Pharmaceuticals
    Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K
    12.04.24 · globenewswire · Eagle Pharmaceuticals
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
    08.02.24 · Business Wire (engl.) · Eagle Pharmaceuticals
    Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
    18.01.24 · globenewswire · Eagle Pharmaceuticals
    ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
    02.01.24 · Business Wire (engl.) · Eagle Pharmaceuticals
    Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors and Encourages Investors to Contact the Firm Before February 9, 2024
    29.12.23 · Business Wire (engl.) · Eagle Pharmaceuticals
    Robbins LLP Reminds Investors of Eagle Pharmaceuticals, Inc. that There is Still Time to Move for Lead Plaintiff in the EGRX Class Action
    27.12.23 · Business Wire (engl.) · Eagle Pharmaceuticals
    Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
    14.12.23 · Business Wire (engl.) · Eagle Pharmaceuticals
    Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Eagle Pharmaceuticals, Inc. (EGRX) Investors
    13.12.23 · Business Wire (engl.) · Eagle Pharmaceuticals
    Eagle Pharmaceuticals, Inc. (EGRX) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Eagle Pharmaceuticals, Inc.
    13.12.23 · Business Wire (engl.) · Eagle Pharmaceuticals
    Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Eagle Pharmaceuticals, Inc. (EGRX)
    13.12.23 · Business Wire (engl.) · Eagle Pharmaceuticals
    EAGLE PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eagle Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    13.12.23 · Business Wire (engl.) · Eagle Pharmaceuticals